mitochondrial biogenesis comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-03-23. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water; stock solutions use organic solvent. |
| Storage | -20°C, desiccated, protected from light | Limits hydrolysis and photodegradation. |
| Analytical method | HPLC-UV/MS | Used for identity and purity assessment. |
| Synonyms | SR9009, Stenabolic | Naming varies by supplier. |
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
Around the end of the 16th century, increasing Cossack aggression strained relations between the Commonwealth and the Ottoman Empire. Cossacks had begun raiding Ottoman territories during the second part of the 16th century. The Polish government could not control them, but was held responsible as the men were nominally its subjects. In retaliation, Tatars living under Ottoman rule launched raids into the Commonwealth, mostly in the southeast territories. Cossack pirates responded by raiding wealthy trading port-cities in the heart of the Ottoman Empire, as these were just two days away by boat from the mouth of the Dnieper river. In 1615 and 1625, Cossacks razed suburbs of Constantinople, forcing the Ottoman Sultan to flee his palace. In 1637, the Zaporozhian Cossacks, joined by the Don Cossacks, captured the strategic Ottoman fortress of Azov, which guarded the Don. The Zaporizhian Cossacks became particularly strong in the first quarter of the 17th century under the leadership of hetman Petro Konashevych-Sahaidachny, who launched successful campaigns against the Tatars and Turks. Tsar Boris Godunov had incurred the hatred of Ukrainian Cossacks by ordering the Don Cossacks to drive away from the Don all the Ukrainian Cossacks fleeing the failed uprisings of the 1590s. This contributed to the Ukrainian Cossacks' willingness to fight against him. In 1604, 2,000 Zaporizhian Cossacks fought on the side of the Polish-Lithuanian Commonwealth and their proposal for the Tsar (Dmitri I), against the Muscovite army.
=== Genetics === An association between biliary atresia and the ADD3 gene was first detected in Chinese populations through a genome-wide association study, and was confirmed in Thai Asians and Caucasians. A possible association with deletion of the gene GPC1, which encodes a glypican 1-a heparan sulfate proteoglycan, has been reported. This gene is located on the long arm of chromosome 2 (2q37) and is involved in the regulation of inflammation and the Hedgehog gene. Egyptian infants with biliary atresia were found to have null GSTM1 genotype while all their mothers were heterozygous for GSTM1. Thus these infants may be protected in utero by their maternal detoxification system, yet once born they cannot handle the detoxification of an aflatoxin load.
Viral coat proteins Autotransporter proteins Intein-containing proteins There are five families of viral coat proteins (N1, N2, N8, N7 and N5), two families of autotransporter proteins (N6 and N4) and three families of intein-containing proteins (N9, N10 and N11).
Sources: en.wikipedia.org
=== Evidence === At trial, the prosecution presented evidence from parents, clinicians and expert witnesses. The mother of Baby E testified that she had heard her son cry and found blood around his mouth while Letby was present; Letby attributed the blood to a nasogastric tube. Baby E died later that day. Letby subsequently sent a sympathy card to the family, photographs of which were later found on her phone. The court also heard that she had been advised more than once not to enter a room where bereaved parents were grieving. Prosecutors cited text messages sent by Letby to colleagues, which they said showed inappropriate interest in clinical events. Messages included offers to take additional intensive‑care shifts shortly after deaths or collapses, expressions of frustration when not allocated to intensive‑care rooms, and comments about fate following a series of deaths. The court also heard that Letby had searched for the families of several infants on Facebook, sometimes on anniversaries or significant dates. She told the jury this reflected general curiosity and frequent phone use. Consultants testified that they believed suspicious incidents began after Letby qualified to work in intensive care in 2015 and that the pattern of collapses shifted after she was moved from night to day shifts in 2016. One consultant said he had found Letby standing over a deteriorating infant in February 2016 and believed she had not intervened promptly; the infant survived.
=== Vasopressin during surgery and anaesthesia === Vasopressin concentration is used to measure surgical stress for evaluation of surgical techniques. Plasma vasopressin concentration is elevated by noxious stimuli, predominantly during abdominal surgery, especially at gut manipulation, traction of viscera, as well as abdominal insufflation with carbon dioxide during laparoscopic surgery.
==== Testosterone ==== Libido in males is linked to concentrations of sex hormones, particularly testosterone. When there is reduced sex drive in individuals with relatively low concentrations of testosterone, particularly in postmenopausal women or men over the age of 60, dietary supplements that are purported to increase serum testosterone concentrations have been used, with the intention of increasing libido, although with limited benefits. Long-term therapy with synthetic oral testosterone is associated with increased risks of cardiovascular diseases.
Sources: en.wikipedia.org
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.
The solid is generally kept cold, dry, and protected from light. Solutions are often frozen in single-use aliquots to reduce repeated freeze-thaw cycles.
It indicates a material sold for laboratory study, not for human use. The label does not guarantee pharmaceutical purity, sterility, or regulatory approval.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.